Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Immunoglobulin G »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Immunoglobulin Fc Fragments < Immunoglobulin G < Immunoglobulin Heavy Chains  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 86.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000610 (2018) Indu Javeri [États-Unis] ; Kaliappanadar Nellaiappan [États-Unis] ; Charles Mcnemar [États-Unis] ; Kirill Yakovlevsky [États-Unis] ; Amina Soukrati [États-Unis] ; Phanindra Velisetty [États-Unis] ; Bijay Misra [États-Unis]Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Mitigate the Interactions of Proteins or Peptide or their Impurities with the Residual Silanols of Commercial SEC-HPLC Columns with Improved Separation and Resolution.
000869 (2018) Huai-Hsuan Chiu [Taïwan] ; Hsiao-Wei Liao [Taïwan] ; Yu-Yun Shao [Taïwan] ; Yen-Shen Lu [Taïwan] ; Ching-Hung Lin [Taïwan] ; I-Lin Tsai [Taïwan] ; Ching-Hua Kuo [Taïwan]Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS.
000933 (2018) Mark A. Russell [Royaume-Uni] ; Manuela Pigors [Royaume-Uni] ; Maha E. Houssen [Égypte] ; Ania Manson [Royaume-Uni] ; David Kelsell [Royaume-Uni] ; Hilary Longhurst [Royaume-Uni] ; Noel G. Morgan [Royaume-Uni]A novel de novo activating mutation in STAT3 identified in a patient with common variable immunodeficiency (CVID).
000968 (2017) Siddiq Anwar [Arabie saoudite] ; M Yousuf Karim [Royaume-Uni]Update on systemic vasculitides.
000E00 (2016) Takeshi Zoshima [Japon] ; Kazunori Yamada ; Satoshi Hara ; Ichiro Mizushima ; Masakazu Yamagishi ; Kenichi Harada ; Yasuharu Sato ; Mitsuhiro KawanoMulticentric Castleman Disease With Tubulointerstitial Nephritis Mimicking IgG4-related Disease: Two Case Reports.
000E85 (2016) Yen-Lin Lin [Taïwan] ; Shun-Hua Chen [Taïwan] ; Jiu-Yao Wang [Taïwan]Critical role of IL-6 in dendritic cell-induced allergic inflammation of asthma.
000F65 (2015) Dorota Suszek ; Arkadiusz Koszarny ; Radosław Jeleniewicz ; Maria Majdan ; Anna Bo Czak ; Agnieszka Czukiewska ; Barbara Koszła ; Sylwia Kurlej ; Justyna Markowicz ; Agnieszka Szymczyk[Biological treatment in severe Still's disease--a case report].
000F76 (2015) O. Shovman [Israël] ; Y. Shoenfeld ; P. LangevitzTocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature.
001059 (2015) Maarit Tarkiainen [Finlande] ; Pirjo Tynj L [Finlande] ; Paula V H Salo [Finlande] ; Pekka Lahdenne [Finlande]Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting.
001063 (2015) Domenico Santoro [Oman] ; Vincenzo Pellican ; Luca Visconti ; Gianluca Trifir ; Valeria Cernaro ; Michele BuemiMonoclonal antibodies for renal diseases: current concepts and ongoing treatments.
001076 (2015) Michaela Cellina [Italie] ; Vincenza Fetoni ; Pierluigi Baron ; Marcello Orsi ; Giancarlo OlivaListeria Meningoencephalitis in a Patient With Rheumatoid Arthritis on Anti-Interleukin 6 Receptor Antibody Tocilizumab.
001102 (2015) Jie Zhang ; Fenglong Xie ; Elizabeth Delzell ; Huifeng Yun ; James D. Lewis ; Kevin Haynes ; Lang Chen ; Timothy Beukelman ; Kenneth G. Saag ; Jeffrey R. CurtisImpact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients.
001108 (2015) Claire Immediato Daïen [France] ; Sarah Gailhac [France] ; Rachel Audo [France] ; Thibault Mura [France] ; Michael Hahne [France] ; Bernard Combe [France] ; Jacques Morel [France]High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis.
001129 (2015) G. Cavalli [Italie] ; S. Franchini ; P. Aiello ; B. Guglielmi ; A. Berti ; C. Campochiaro ; M G Sabbadini ; E. Baldissera ; L. DagnaEfficacy and safety of biological agents in adult-onset Still's disease.
001131 (2015) Toshihiro Tono [Japon] ; Satoko Aihara ; Takayuki Hoshiyama ; Yoshiyuki Arinuma ; Tatsuo Nagai ; Shunsei HirohataEffects of anti-IL-6 receptor antibody on human monocytes.
001156 (2015) Maria K. Kvamme [Norvège] ; Elisabeth Lie [Norvège] ; Till Uhlig [Norvège] ; Tron A. Moger [Norvège] ; Tore K. Kvien [Norvège] ; Ivar S. Kristiansen [Norvège]Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a Markov model study based on two longitudinal observational studies.
001300 (2014) E. Bizzi [Oman] ; U. Massafra ; B. Laganà ; V. Bruzzese ; A Picchianti Diamanti ; M. Cassol ; A. MiglioreRadiological outcomes in randomized controlled trials on biologic therapies for rheumatoid arthritis: a narrative review.
001306 (2014) Tamao Nakashita [Japon] ; Katsutoshi Ando [Japon] ; Norihiro Kaneko [Japon] ; Kazuhisa Takahashi [Japon] ; Shinji Motojima [Japon]Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis.
001341 (2014) Hiba M. Shendi [Royaume-Uni] ; Lisa A. Devlin ; John David EdgarInterleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome.
001378 (2014) Joaquín Borrás-Blasco [Oman] ; M Dolores-Elvira Casterá ; Xavier Cortes ; J Dolores Rosique-Robles ; F Javier AbadEconomical impact associated with a biological therapy prioritization protocol in patients with rheumatoid arthritis in the Hospital of Sagunto.
001393 (2014) Jeroen P. Jansen ; Felicity Buckley [États-Unis] ; Fred Dejonckheere ; Sarika OgaleComparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Immunoglobulin G" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Immunoglobulin G" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Immunoglobulin G
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021